📊 STEK Key Takeaways
Is Stemtech Corp (STEK) a Good Investment?
Stemtech Corp is technically insolvent with negative stockholders equity of -$5.8M, unable to support operations with a 0.10x current ratio indicating acute liquidity crisis. The company is burning cash at -$610.6K operationally with anemic 2.7% revenue growth, negative operating margins of -76.3%, and insufficient cash reserves ($255.4K) to sustain ongoing losses.
Why Buy Stemtech Corp Stock? STEK Key Strengths
- High gross margin of 80.8% suggests underlying product/service unit economics could be viable if operational efficiency improves
STEK Stock Risks: Stemtech Corp Investment Risks
- Technical insolvency: stockholders equity of -$5.8M means liabilities exceed all assets by majority stake
- Critical liquidity crisis: current ratio of 0.10x and quick ratio of 0.08x indicate inability to meet short-term obligations
- Negative operating cash flow of -$610.6K burning cash runway with only $255.4K in reserves
- Unsustainable losses: -$1.8M operating loss and -$2.6M net loss on $2.4M revenue base
- Debt burden: $4.1M long-term debt with -0.2x interest coverage ratio, unable to service from operations
- Stalled growth: only 2.7% YoY revenue growth indicates market contraction or competitive losses
Key Metrics to Watch
- Stockholders equity stabilization and trend toward positive territory
- Operating cash flow trajectory and path to cash flow breakeven
- Cash runway depletion rate and covenant compliance with creditors
- Revenue stabilization or growth re-acceleration above 2.7%
- Debt restructuring negotiations or refinancing activities
Stemtech Corp (STEK) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
STEK Profit Margin, ROE & Profitability Analysis
STEK vs Market Sector: How Stemtech Corp Compares
How Stemtech Corp compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Stemtech Corp Stock Overvalued? STEK Valuation Analysis 2026
Based on fundamental analysis, Stemtech Corp has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Stemtech Corp Balance Sheet: STEK Debt, Cash & Liquidity
STEK Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Stemtech Corp's revenue has grown significantly by 15% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.07 indicates the company is currently unprofitable.
STEK Revenue Growth, EPS Growth & YoY Performance
STEK Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $852.3K | -$809.4K | $-0.01 |
| Q2 2025 | $697.9K | -$293.1K | $0.00 |
| Q1 2025 | $868.0K | -$1.4M | $-0.01 |
| Q2 2024 | $1.1M | -$286.9K | $0.00 |
| Q1 2024 | $1.1M | -$1.4M | $-0.02 |
| Q3 2023 | $1.0M | -$1.0M | $-0.01 |
| Q2 2023 | $1.1M | -$286.9K | $0.00 |
| Q1 2023 | $1.1M | -$494.7K | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Stemtech Corp Dividends, Buybacks & Capital Allocation
STEK SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Stemtech Corp (CIK: 0001511820)
📋 Recent SEC Filings
❓ Frequently Asked Questions about STEK
What is the AI rating for STEK?
Stemtech Corp (STEK) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are STEK's key strengths?
Claude: High gross margin of 80.8% suggests underlying product/service unit economics could be viable if operational efficiency improves.
What are the risks of investing in STEK?
Claude: Technical insolvency: stockholders equity of -$5.8M means liabilities exceed all assets by majority stake. Critical liquidity crisis: current ratio of 0.10x and quick ratio of 0.08x indicate inability to meet short-term obligations.
What is STEK's revenue and growth?
Stemtech Corp reported revenue of $2.4M.
Does STEK pay dividends?
Stemtech Corp does not currently pay dividends.
Where can I find STEK SEC filings?
Official SEC filings for Stemtech Corp (CIK: 0001511820) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is STEK's EPS?
Stemtech Corp has a diluted EPS of $-0.02.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is STEK a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Stemtech Corp has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is STEK stock overvalued or undervalued?
Valuation metrics for STEK: ROE of N/A (sector avg: 15%), net margin of -106.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy STEK stock in 2026?
Our dual AI analysis gives Stemtech Corp a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is STEK's free cash flow?
Stemtech Corp's operating cash flow is $-610.6K, with capital expenditures of $0.0. FCF margin is -25.2%.
How does STEK compare to other Market stocks?
Vs Default sector averages: Net margin -106.0% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.10 (avg: 1.8).